Research Article

The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity

Volume: 12 Number: 2 August 22, 2022
EN

The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity

Abstract

Objective: The objective of the current work is to examine the protective effects of S-methyl methionine sulfonium chloride (MMSC) on brain in galactosamine (GalN)-induced hepatotoxicity in rats.

Materials and Methods: A total of twenty two female Sprague-Dawley rats were randomly assigned into four groups as follows: Group I (n=5), intact control animals; Group II (n=6), animals that received 50 mg/kg/day of MMSC by gavage technique for 3 consecutive days; Group III (n=5), animals injected with a single dose of 500 mg/kg of GalN intraperitoneally (i.p.); and Group IV (n=6) are animals injected with the same dose of GalN (i.p.) 1 hour after MMSC treatment. At the end of the experiments (after 6 hours of the last GalN treatment), all animals were sacrificed under anaesthesia, and brain tissues were dissected out.

Results: A statistically remarkable increase in lipid peroxidation, hydroxyproline, and nitric oxide levels, was detected while a notable decline in the activities of sodium/potassium ATPase was observed in GalN group in comparison with control rats. In contrast, all alterations observed were reversed when MMSC was given to GalN groups.

Conclusion: Consequently, it may be considered that MMSC has a protective role on brain in GalN-induced hepatotoxicity in rats

Keywords

References

  1. 1. Singh G, Sharma R. Animal models for hepatoxicity. In: Sobti RC, editor. Advances in Animal Experimentation and Modeling. Aca-demic Press: London; 2022.p.195-203. google scholar
  2. 2. Rouf A, Das AK, Khatoon MSTM, Mitu NL, Shahriar M. Evaluation of hepatoprotective effects of arogyavardhini against D-galac-tosamine-induced hepatotoxicity in rats. J Pharmacog Phyto-chem 2021; 10(1): 12-9. google scholar
  3. 3. Dong W, Song E, Song Y. Co-administration of lipopolysaccharide and D-galactosamine induces genotoxicity in mouse liver. Sci Rep 2021; 11: 1733. [CrossRef] google scholar
  4. 4. Hajam YA, Rani R, Ganie SY, Sheikh TA, Javaid D, Qadri SS, et al. Oxidative stress in human pathology and aging: molecular mech-anisms and perspectives. Cells 2022; 11(3): 552. [CrossRef] google scholar
  5. 5. Anwar MM. Oxidative stress-a direct bridge to central nervous system homeostatic dysfunction and Alzheimer's disease. Cell Biochem Funct 2022; 40(1): 17-27. [CrossRef] google scholar
  6. 6. Choi EH, Lee SB, Lee DY, Kim GT, Shim SM, Park TS. Increased in-testinal absorption of vitamin U in steamed graviola leaf extract activates nicotine detoxification. Nutrients 2019; 11(6): 1334. [CrossRef] google scholar
  7. 7. Oktay S, Bayrak G, Alev B, Ipekci H, Ustundag UV, Turkyilmaz IB, et al. The effect of vitamin U on the lung tissue of pentylenetera-zole-induced seizures in rats. Naunyn-Schmiedeberg's Arch Phar-macol 2018; 391(2): 177-84. [CrossRef] google scholar
  8. 8. Gezginci-Oktayoglu S, Turkyilmaz IB, Ercin M, Yanardag R, Bolkent S. Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fi-brotic properties. Protoplasma 2016; 253(1): 127-35. [CrossRef] google scholar

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

August 22, 2022

Submission Date

March 10, 2022

Acceptance Date

June 6, 2022

Published in Issue

Year 2022 Volume: 12 Number: 2

APA
Bayrak, B. B., Mahmarzayeva, D., Türkyılmaz, İ. B., Saçan, Ö., & Yanardağ, R. (2022). The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity. Experimed, 12(2), 38-43. https://doi.org/10.26650/experimed.1085407
AMA
1.Bayrak BB, Mahmarzayeva D, Türkyılmaz İB, Saçan Ö, Yanardağ R. The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity. Experimed. 2022;12(2):38-43. doi:10.26650/experimed.1085407
Chicago
Bayrak, Bertan Boran, Dastagul Mahmarzayeva, İsmet Burcu Türkyılmaz, Özlem Saçan, and Refiye Yanardağ. 2022. “The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity”. Experimed 12 (2): 38-43. https://doi.org/10.26650/experimed.1085407.
EndNote
Bayrak BB, Mahmarzayeva D, Türkyılmaz İB, Saçan Ö, Yanardağ R (August 1, 2022) The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity. Experimed 12 2 38–43.
IEEE
[1]B. B. Bayrak, D. Mahmarzayeva, İ. B. Türkyılmaz, Ö. Saçan, and R. Yanardağ, “The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity”, Experimed, vol. 12, no. 2, pp. 38–43, Aug. 2022, doi: 10.26650/experimed.1085407.
ISNAD
Bayrak, Bertan Boran - Mahmarzayeva, Dastagul - Türkyılmaz, İsmet Burcu - Saçan, Özlem - Yanardağ, Refiye. “The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity”. Experimed 12/2 (August 1, 2022): 38-43. https://doi.org/10.26650/experimed.1085407.
JAMA
1.Bayrak BB, Mahmarzayeva D, Türkyılmaz İB, Saçan Ö, Yanardağ R. The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity. Experimed. 2022;12:38–43.
MLA
Bayrak, Bertan Boran, et al. “The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity”. Experimed, vol. 12, no. 2, Aug. 2022, pp. 38-43, doi:10.26650/experimed.1085407.
Vancouver
1.Bertan Boran Bayrak, Dastagul Mahmarzayeva, İsmet Burcu Türkyılmaz, Özlem Saçan, Refiye Yanardağ. The Protective Effects of S-Methyl Methionine Sulfonium Chloride on Brain Tissue Damage in D-Galactosamine-Induced Hepatotoxicity. Experimed. 2022 Aug. 1;12(2):38-43. doi:10.26650/experimed.1085407